Get in touch today 206.598.4100 or

Schedule an Appointment

Edward Kim, MD

Associate Professor


Dr. Kim is a radiation oncologist who specializes in the treatment of gastrointestinal cancers, sarcoma, intraoperative radiotherapy, and intravascular brachytherapy. Dr. Kim is the University of Washington Department of Radiation Oncology program and disease site lead for gastrointestinal cancers.   He is also the Medical Director for the Radiation Oncology Department at the UW Medical Center.  Dr. Kim practices at UWMC, SCCA, and SCCA Proton Therapy Center.

Patient Care Philosophy

“I believe in individualized care and making decisions with my patients as a partnership.”

Education and Training

College: Case Western Reserve University, Cleveland, OH, 1998

Medical Education: Case Western Reserve University School of Medicine, Cleveland, OH, 2001

Internship: University Hospitals of Cleveland Internal Medicine, Cleveland, OH, 2002

Residency: Case Comprehensive Cancer Center, Cleveland, OH, 2007

Selected Publications from a Total of 31

Wootton L, Meyer J, Kim E, Phillips M. Commissioning, clinical implementation, and performance of the Mobetron 2000 for intraoperative radiation therapy. J Appl Clin Med Phys 2017, 230-42

Chvestov A, Rajendran J, Zeng J, Patel S, Bowen S, Kim E, Theoretical effectiveness of cell survival during fractionated radiotherapy with hypoxia-targeted dose escalation, Med Phys 2017, In Press

Richard P, Phillips M, Smith W, Davidson D, Kim E, Kane G, Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas. Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):999-1008

Lo S, Ryu S, Chang E, Galanapoulos N, Jones J, Kim E, Kubicky C, Lee C, Rose P, Sahgal A, Sloan A, The B, Traughber B, Van Poznak C, Vassil A. ACR Appropriateness Criteria Metastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis. J Palliat Med 2015, 18(7),

Kim EY, Chapman TR, Ryu S, Chang EL, Galanopoulos N, Jones J, Kubicky CD, Lee CP, Teh BS, Traughber BJ, Van Poznak C, Vassil AD, Weber K, Lo SS.. ACR Appropriateness Criteria(®) non-spine bone metastases. J Palliat Med. 2015 Jan;18(1):11-7

Thomas TO, Hasan S, Small W Jr, Herman JM, Lock M, Kim EY, Mayr NA, Teh BS, Lo SS. The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far? J Gastrointest Oncol. 2014 Jun;5(3):236-46.

Lo S, Lutz ST, Chang RL, Galanopoulos N, Howell D, Kim EY, Konski A, Pandit-Taskar N, Rose P, Ryu S, Silverman L, Sloan A, Van Poznak C. ACR Appropriateness Criteria Spinal Bone Metastases. J Palliat Med 2013, 16(1), 1-11

Guiou M, Mayr N, Kim E, Williams T, Lo S. Stereotactic body radiotherapy for adrenal metastases from lung cancer. J Radiat Oncol 2012, 1:155-63.

Lutz EP, Lo SS, Chang EL, Galanopoulos N, Howell DD, Kim EY, Konski AA, Pandit-Taskar ND, Ryu S, Silverman LN, Van Poznak C, Weber KL. ACR Appropriateness Criteria® Non-Spine Bone Metastases. J Palliat Med. 2012 May;15(5):521-6.

Chen WC, Kim J, Kim E, Silverman P, Overmoyer B, Cooper BW, Anthony S, Shenk R, Leeming R, Hanks SH, Lyons JA. A Phase II Study of Radiotherapy and Concurrent Paclitaxel Chemotherapy in Breast-Conserving Treatment for Node-Positive Breast Cancer., Int J Radiat Oncol Biol Phys. 2012 Jan, 82(1): 14-20

Research Interests

  • Gastrointestinal tumors
  • Radiotherapy for Sarcomas: imaging response
  • Radiotherapy for Sarcomas in combination with immunotherapy
  • Intraoperative radiotherapy